Harvard Bioscience
(HBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,355 | -1,830 | 2,370 | 3,812 | 19,015 |
| Depreciation Amortization | 3,939 | 4,035 | 4,258 | 4,418 | 4,006 |
| Income taxes - deferred | 1,412 | -2,441 | -731 | -849 | -11,732 |
| Accounts receivable | -735 | 436 | 1,154 | 232 | -1,088 |
| Accounts payable and accrued liabilities | 1,069 | -41 | -905 | 69 | 56 |
| Other Working Capital | -4,514 | 1,940 | 256 | -3,854 | -1,237 |
| Other Operating Activity | 825 | 1,961 | 1,660 | 2,820 | 3,273 |
| Operating Cash Flow | $4,351 | $4,060 | $8,062 | $6,648 | $12,293 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -864 | -1,556 | -1,736 | -1,481 | -813 |
| Net Acquisitions | -12,653 | 1,784 | -2,878 | -5,465 | -7,115 |
| Other Investing Activity | 0 | -57 | -62 | -252 | -418 |
| Investing Cash Flow | $-13,517 | $171 | $-4,676 | $-7,198 | $-8,346 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,200 | 14,550 | 500 | N/A | 10,350 |
| Debt Repayment | -5,500 | N/A | -3,850 | -1,708 | -5,663 |
| Common Stock Issued | 2,066 | 3,621 | 2,287 | 567 | 282 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -5,000 |
| Other Financing Activity | 0 | -18,103 | 0 | 0 | 0 |
| Financing Cash Flow | $-1,234 | $68 | $-1,063 | $-1,141 | $-31 |
| Exchange Rate Effect | -1,237 | 791 | 442 | -97 | -800 |
| Beginning Cash Position | 25,771 | 20,681 | 17,916 | 19,704 | 16,588 |
| End Cash Position | 14,134 | 25,771 | 20,681 | 17,916 | 19,704 |
| Net Cash Flow | $-11,637 | $5,090 | $2,765 | $-1,788 | $3,116 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,351 | 4,060 | 8,062 | 6,648 | 12,293 |
| Capital Expenditure | -2,005 | -1,622 | -1,769 | -1,506 | -844 |
| Free Cash Flow | 2,346 | 2,438 | 6,293 | 5,142 | 11,449 |